Search the website | European Medicines Agency

Search the website

Use this page to find content on this website. For help on how to get the results you want, see our search tips.

Search results

Categories

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Product number

Patient safety

Authorisation status

ATC code

Marketing authorisation date

Marketing authorisation holder

Pharmacotherapeutic group

Date of opinion

Medicine type

Therapeutic area

Topic

Last updated

First published

10 results

Sort by

List item

Human medicine European public assessment report (EPAR): Lemtrada (updated)

alemtuzumab, Multiple Sclerosis
Date of authorisation: 12/09/2013, , , Revision: 11, Authorised, Last updated: 25/03/2021
List item

Human medicine European public assessment report (EPAR): Capecitabine Accord (updated)

capecitabine, Colonic Neoplasms, Breast Neoplasms, Colorectal Neoplasms, Stomach Neoplasms
Date of authorisation: 20/04/2012, , , Revision: 13, Authorised, Last updated: 22/03/2021
List item

Human medicine European public assessment report (EPAR): Capecitabine Teva (updated)

capecitabine, Colonic Neoplasms, Breast Neoplasms, Colorectal Neoplasms, Stomach Neoplasms
Date of authorisation: 20/04/2012, , , Revision: 14, Authorised, Last updated: 17/03/2021
List item

Human medicine European public assessment report (EPAR): Capecitabine Medac

capecitabine, Colorectal Neoplasms
Date of authorisation: 19/11/2012, , , Revision: 11, Authorised, Last updated: 10/03/2021
List item

Human medicine European public assessment report (EPAR): Gilenya

fingolimod hydrochloride , Multiple Sclerosis
Date of authorisation: 17/03/2011, , , Revision: 28, Authorised, Last updated: 04/02/2021
List item

Human medicine European public assessment report (EPAR): Xarelto

rivaroxaban, Arthroplasty, Replacement, Venous Thromboembolism
Date of authorisation: 30/09/2008, , , Revision: 33, Authorised, Last updated: 02/02/2021
List item

Human medicine European public assessment report (EPAR): Xeljanz

tofacitinib citrate, Arthritis, Rheumatoid
Date of authorisation: 21/03/2017,
Date of refusal: 25/04/2013, , , Revision: 16, Authorised, Last updated: 28/01/2021
List item

Human medicine European public assessment report (EPAR): Picato

Ingenol mebutate, Keratosis, Actinic
Date of authorisation: 15/11/2012, , , Revision: 10, Withdrawn, Last updated: 31/07/2020
List item

Human medicine European public assessment report (EPAR): Ecansya (previously Capecitabine Krka)

capecitabine, Colonic Neoplasms, Breast Neoplasms, Colorectal Neoplasms, Stomach Neoplasms
Date of authorisation: 20/04/2012, , , Revision: 12, Authorised, Last updated: 31/07/2020
List item

Human medicine European public assessment report (EPAR): Lartruvo

Olaratumab, Sarcoma
Date of authorisation: 09/11/2016, , , , , Revision: 3, Withdrawn, Last updated: 02/09/2019